RETROSPECTIVE ANALYSIS OF THE INHIBITOR FORM OF HEMOPHILIA A IN CHILDREN

MAKHMUDOVA Dilorom Salakhitdinovna, SHADIBEKOVA Oksana Bronislavovna, ALMEDOVA Nargiza Nigmadganovna, DEKHKANOV Sattor Kakhramonovich, MUSTAFAYEV Arseniy Ruslanovich

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali · 2026-yil

Annotatsiya

Baseline factor VIII activity level cannot serve as a reliable clinical predictor of inhibitor development. Given the high frequency of this complication, regular laboratory screening for antibodies is justified for all patients receiving replacement therapy, regardless of the severity of the disease phenotype.

Maqola ma’lumotlari
MualliflarMAKHMUDOVA Dilorom Salakhitdinovna, SHADIBEKOVA Oksana Bronislavovna, ALMEDOVA Nargiza Nigmadganovna, DEKHKANOV Sattor Kakhramonovich, MUSTAFAYEV Arseniy Ruslanovich
JurnalJournal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
Nashr sanasi2026-08-06
Jild11
Son3
TilRus

Kalit so‘zlar

гемофилия А, ингибиторная форма, фактор VIII, Bethesda, титр ингибиторных антител, hemophilia A, inhibitor form, factor VIII, Bethesda units, inhibitor antibody titer, gemofiliya A, ingibitor shakli, VIII omil, Bethesda, ingibitor antitanalar titri

Ilmiy soha

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali jurnalidan boshqa maqolalar

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar